Crystal forms of anamorelin
US9975921B2 · kind B2 · utility
0Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2015 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | Oct 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0202
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Crystalline forms of anamorelin which are useful as pharmaceutical agents are disclosed. Methods of production and isolation of these polymorphs and pharmaceutical compositions which include these polymorphs and pharmaceutical methods of treatment are also disclosed. The crystalline polymorphs of the present invention are useful as they act directly on the pituitary gland cells to release growth hormone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.